| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGACCCCCAGCCUUUUGUGCGCCGCGCGGUGGGGCGGUGCCCAGCUUGG… | 2661 nt | 0.5239 | |
| CUCUCAGAACCUUCCUGCCGUCGCGUUUGCACCUCGCUGCUCCAGCCUC… | 1909 nt | 0.4924 | |
| CUCUCAGAACCUUCCUGCCGUCGCGUUUGCACCUCGCUGCUCCAGCCUC… | 2383 nt | 0.5065 | |
| AGACCCCCAGCCUUUUGUGCGCCGCGCGGUGGGGCGGUGCCCAGCUUGG… | 2564 nt | 0.5234 | |
| AGACCCCCAGCCUUUUGUGCGCCGCGCGGUGGGGCGGUGCCCAGCUUGG… | 2463 nt | 0.5201 | |
| CUCUCAGAACCUUCCUGCCGUCGCGUUUGCACCUCGCUGCUCCAGCCUC… | 2515 nt | 0.5105 |
This gene encodes a beta tubulin protein. This protein forms a dimer with alpha tubulin and acts as a structural component of microtubules. Mutations in this gene cause cortical dysplasia, complex, with other brain malformations 6. Alternative splicing results in multiple splice variants. There are multiple pseudogenes for this gene on chromosomes 1, 6, 7, 8, 9, and 13. [provided by RefSeq, Jun 2014]
A study in mice demonstrated that following clodronate pre-treatment and controlled cortical impact injury, a distinct neutrophil-like monocyte cluster (C9) emerged, characterized by upregulated expression of proliferative phenotype genes including the TUBB [Gudenschwager Basso et al. DOI:10.1186/s12974-024-03032-8]. The adoptive transfer of these monocytes from treated donors into injured recipient mice directly conferred neuroprotection, reducing lesion volume and improving cerebral blood flow. A study in humans demonstrated that the TUBB is a blood-specific mRNA marker selected as a candidate gene from microarray analysis [Park et al. DOI:10.1016/j.fsigen.2012.09.001]. A subsequent human study developed a massively parallel sequencing assay incorporating the TUBB among other genes, where it functioned as a blood-specific marker for both body fluid identification and donor association in complex mixtures, with the assay achieving a discriminatory power for blood of 0.99999999827 [Liu et al. DOI:10.1016/j.fsigen.2024.103066].